KPMG's latest report on China's life science sector notes that the country is set to become a crucial player in the life science and healthcare industry. Within a decade it is expected to become a global leader in drug discovery and innovation.
This report makes a compelling read for any organisation that is either planning or implementing a cloud strategy, and provides some practical and actionable advice for enterprises and their executives.
This publication explains why China is no longer a 'maybe' destination for companies operating shared services facilities. It outlines the life cycle of shared services and explores some of the challenges specific to setting up in China.
Related links
RSS feeds
Subscribe to receive email alerts or e-Newsletters from KPMG China when new updates are available.
Business Issues in China - This overview takes a general look at the China market, and gives key insights into new developments.